Skip to content
← Back to this collection

PUBLICATIONS · 11781223

Real-time quantitation of minimal residual disease in inv(16)-positive acute myeloid leukemia may indicate risk for clinical relapse and may identify patients in a curable state.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Blood
Publication date
2002 Jan 15
First author
Buonamici S

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Buonamici S
      type
      Author
    2. name
      Ottaviani E
      type
      Author
    3. name
      Testoni N
      type
      Author
    4. name
      Montefusco V
      type
      Author
    5. name
      Visani G
      type
      Author
    6. name
      Bonifazi F
      type
      Author
    7. name
      Amabile M
      type
      Author
    8. name
      Terragna C
      type
      Author
    9. name
      Ruggeri D
      type
      Author
    10. name
      Piccaluga PP
      type
      Author
    11. name
      Isidori A
      type
      Author
    12. name
      Malagola M
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Buonamici S
      type
      Author
    2. name
      Ottaviani E
      type
      Author
    3. name
      Testoni N
      type
      Author
    4. name
      Montefusco V
      type
      Author
    5. name
      Visani G
      type
      Author
    6. name
      Bonifazi F
      type
      Author
    7. name
      Amabile M
      type
      Author
    8. name
      Terragna C
      type
      Author
    9. name
      Ruggeri D
      type
      Author
    10. name
      Piccaluga PP
      type
      Author
    11. name
      Isidori A
      type
      Author
    12. name
      Malagola M
      type
      Author
    bibliography ids
    1. nci-bib-3ea47cbb8a070c98bc5aa450
    book metadata
    content sha256
    9048984bafae907f64df84a1ff6680c84eab5b7aff80e2d7fabf029eaaca68f6
    document type
    citation
    dois
    1. 10.1182/blood.v99.2.443
    electronic publication date
    display
    Source null
    precision
    missing
    year
    Source null
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:11781223
    immutable id
    pubmed:11781223@9048984bafae907f64df84a1ff6680c84eab5b7aff80e2d7fabf029eaaca68f6
    journal
    abbreviation
    Blood
    issn electronic
    Source null
    issn print
    0006-4971
    issue
    2
    name
    Blood
    nlm unique id
    7603509
    pages
    443-9
    volume
    99
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      11781223
      provenance
      batch id
      d4e82e28940c878dd0a2
      provider
      NCBI PubMed ESummary
      record sha256
      7e0b7466931104de17c55c60049d7d9ab68d594b2546fd6e28a12695b4bbf161
      response sha256
      257c7530b1505623f6712628a73c1e9b8b3119838f4ec701e62de2dab9d87468
      retrieved at
      2026-09-09T23:45:44.017762+00:00
      publication date
      display
      2002 Jan 15
      precision
      day
      year
      2002
      publication types
      1. Evaluation Study
      2. Journal Article
      3. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/11781223/
      title
      Real-time quantitation of minimal residual disease in inv(16)-positive acute myeloid leukemia may indicate risk for clinical relapse and may identify patients in a curable state.

      Preserved source evidence · Not medical advice